Elevated lung cancer risk associated with the variant C allele of TP53 SNP rs1042522 observed in this study was consistent with previous studies conducted among the Asian populations (summarized OR under recessive genetic model: 1.37, 95% CI: 1.20 – 1.57; homozygote comparison CC vs. GG: 1.34, 95% CI: 1.16 – 1.56) [8]. This evidence concerns the gene TP53 and lung cancer.